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Abstract: The oviduct is the anatomical part of the female reproductive tract where the early 
reproductive events take place, from gamete transport, fertilization and early embryo development 
to the delivery of a competent embryo to the uterus, which can implant and develop to term. The 
success of all these events rely upon a two-way dialogue between the oviduct (lining epithelium and 
secretions) and the gametes/embryo(s). Recently, extracellular vesicles (EVs) have been identified as 
major components of oviductal secretions and pointed to as mediators of the gamete/embryo-maternal 
interactions. EVs, comprising exosomes and microvesicles, have emerged as important agents of cell-
to-cell communication by the transfer of biomolecules (i.e., mRNAs, miRNAs, proteins) that can 
modulate the activities of recipient cells. Here, we provide the current knowledge of EVs in the 
oviductal environment, from isolation to characterization, and a description of the EVs molecular 
content and associated functional aspects in different species. The potential role of oviductal EVs 
(oEVs) as modulators of gamete/embryo-oviduct interactions and their implications in the success of 
early reproductive events is addressed. Lastly, we discuss current challenges and future directions 
towards the potential application of oEVs as therapeutic vectors to improve pregnancy disorders, 
infertility problems and increase the success of assisted reproductive technologies. 
Keywords: extracellular vesicles; exosomes; microvesicles; oviduct; gamete/embryo-oviduct 
interactions 
 
1. Introduction 
Maternal interactions with gametes and embryo(s) are considered as the basis for reproductive 
success [1,2]. Transcriptomic and proteomics studies have demonstrated that these interactions start 
in the oviduct, the anatomical tube connecting the ovary and the uterus [3–7]. The oviduct provides 
the optimal microenvironment for gamete maturation, transport, and the guidance of spermatozoa 
towards the oocyte(s) leading to successful fertilization, as well as supporting very early embryo 
development [8,9]. Moreover, the oviduct has been pointed to as a modulator of the epigenetic 
landscape of the embryo [10]. Increasing evidence from human and animal models indicates that the 
use of assisted reproductive technologies (ARTs), such as intracytoplasmic sperm injection or in vitro 
fertilization, which bypasses these gamete/embryo-oviductal interactions, are associated with 
genomic imprinting disorders [11,12]. These findings call for a better understanding of the complex 
oviductal environment that can be mimicked by embryologists and reproductive biologists in the 
laboratory, to increase the success of ARTs. 
Considering the complex role of the oviduct in the early reproductive events, efforts have been 
directed to unravel the composition of the oviductal milieu under different reproductive scenarios: 
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under different hormonal regulation or in response to spermatozoa/embryos. Having a look into the 
literature, studies can be divided in two different approaches: (1) focusing on oviductal epithelial 
cells (OEC) [4,7,13–17], and (2) focusing on the oviductal fluid/secretions [18–21]. As a result, a large 
number of oviductal components, including hormones, growth factors and their receptor, enzymes, 
have been detected in oviduct and/or oviductal fluid. The list of oviductal proteins is increasing every 
year with the use of more sensitive mass spectrometer instruments. However, the question that arises 
is how all these individual components may interact with spermatozoa/embryos or be taken up by 
them to exert a functional effect. 
Recently, oviductal extracellular vesicles (EVs) have been identified as major components of the 
oviductal fluid and potential mediators of the gamete/embryo maternal interactions [22–24]. EVs, 
referred to as exosomes (40–100 nm) and microvesicles (>100 to 1000 nm), are present in most body 
fluids and have emerged as a new way of cell-to-cell communication [25]. EVs contain a repertoire of 
bioactive molecules such as proteins, mRNAs, small ncRNAs, lipids and also, genomic DNA [25]. 
Interestingly, this molecular cargo is protected from extracellular degradation or modification [26]. 
Besides, the cargo reflects the physiological and pathological status of the cell of origin [25]. 
Furthermore, the molecular components can be transferred to recipient cells and exert a functional 
effect in the recipient cell (reviewed by [27]). These intrinsic characteristics of EVs make them great 
biomarkers of infertility/pregnancy failure and potential therapeutic agents in ART and fertility 
treatments [26,28–30].  
To date, oviductal EVs (oEVs) have been identified in the oviductal fluid of different species 
(mouse [22,31], cow [23,24], woman: [32], hen [33], bitch [34] and turtle [35]). However, little is known 
about the oEVs molecular content and associated functions, compared to other maternal reproductive 
EVs such as uterine EVs or follicular fluid EVs. Few studies have shown that oEVs can exert a 
functional effect on sperm, by enhancing sperm fertilizing ability [22,32] and as well as on the embryo, 
by improving embryo development and cryoresistance [23,24] and enhancing the efficiency of 
embryo transfer by increasing the birth rate [36]. While only three studies have brought some light 
into the oEVs molecular cargo [31,37]. The scant information on oEVs emphasize the need for deeper 
analyses of their molecular composition and functional effects, which will bring a better 
understanding of the oEVs contribution to the gamete/embryo-oviduct dialog and their implications 
in the reproductive success.  
The objective of this review is to highlight recent progress and challenges in oEVs research to 
increase our understanding about the role of oEVs in the oviduct and their implications in the 
reproductive success, since gametes and embryos are surrounded by oEVs during a short time frame 
but with huge consequences persisting into adulthood. 
2. Studies on Oviductal EVs 
Despite the fact that EVs were discovered almost four decades ago [38], oEVs were identified 
quite recently in the murine oviductal fluid by Al-Dossary and colleagues [22], who dubbed them 
“Oviductosomes”. This term was used to align with the terms used for EVs identified in the male 
reproductive tract (epididymosomes and prostasomes [39,40]) and in the female tract (uterosomes 
[41]). Oviductal EVs vary in origin and size and according to that have been classified into two 
categories: 1) exosomes arising from endosomes with 40–100nm in size (or 30–200nm, depending on 
literature); and 2) microvesicles budding from the plasma membrane and with a size between 100 
nm–1 m. Current state-of-the-art analysis of the biology of exosomes and microvesicles can be found 
in detail in van Niel et al, [27] and related to the reproductive field in Simon et al. [26]. To clarify, the 
term oviductosomes or oEVs refers to both exosomes and microvesicles, and in the present review 
we will refer to them as oEVs.  
Considering the existing literature on oEVs, it calls our attention that the number of publications 
focused on oEVs is lower than for other EVs derived from the maternal tract, such as uterine EVs and 
follicular fluid EVs. The low number of studies on oEVs could be due to: 1) the difficulty in collecting 
oviductal fluid samples, since to obtain it, animals need to be slaughtered or subjected to surgery; 
and/or 2) the underestimated role of the oviductal milieu [42,43] on sperm/embryo and for extension 
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oEVs. Compared to the uterus, embryo spend only a short time in the oviduct (from two to six days 
depending on the species). Furthermore, embryos can be produced in vitro, develop up to day seven 
and then establish a pregnancy after embryo transfer, despite their quality is inferior than in vivo 
embryos [44]. 
Before entering into the discussion of current studies on oEVs, we consider it important to look 
at different isolation and purification techniques used by oEVs studies. It is known that different 
isolation methods can lead to the collection of different populations of exosomes/microvesicles (MVs) 
[45] and also that the methodology affects the exosome yield and composition of the molecular cargo 
in terms of omics profiles of exosome populations [46]. It is worth mentioning that all oEVs studies 
found in current literature used ultracentrifugation/serial centrifugation as the preferential method 
to isolate EVs, in contrast to other maternally-derived EVs or EVs from different biological fluids 
(urine, serum, saliva, etc.), where different methods were used (density gradient centrifugation, 
polymer-based precipitation, and immunoaffinity as well as commercial kits such as ExoQuick™ 
precipitation or the Total Exosome Isolation™ precipitation solution). Detailed comparative analyses 
among EVs isolation methods have been performed and reviewed in the literature [47–55] and are 
not the focus of this review. Here, we will focus on the pros and cons of the use of ultracentrifugation 
since it has been the method used in all studies of oEVs so far. 
The selection of ultracentrifugation as the common method among all oEVs could be random, 
or could be due to the fact that most publications have aimed to analyse the functional effects of EVs 
on gametes/embryos. Ultracentrifugation is considered the gold standard method for exosome 
isolation and the most widely applied in EVs studies [46,56]. It is the preferred method to obtain EVs 
for downstream analysis and for performing further experiments on biological functions, despite the 
low exosome yield and contamination with impurities. As Lötvall and colleagues pointed out, some 
density gradients or immunoaffinity methods often used for EV isolation, with better yield and 
exosome purity, may alter or impede functional tests [57]. So far, ultracentrifugation seems the 
preferred method for subsequent use of EVs pellet in flow-cytometry, proteomics, lipidomics, RNA, 
and biological studies at the same time. Furthermore, the use of ultracentrifugation can help to 
preserve the integrity and the biological activity of isolated EVs as well as the sterility, which is an 
important point for functional experiments of oEVs with gametes and embryos. Additionally, recent 
studies have pointed out that it is important to keep the exact same protocol with differential 
centrifugation steps, when comparative studies on EVs are performed. Since the different types of 
rotors and the specific tubes used for these rotors can affect the k-factor, as well as centrifugation 
time, producing 2–3-fold differences in pellet yield [47]. 
Regarding oEVs characterization, most studies have chosen as least two methods, one based on 
morphology (or single vesicle analysis such transmission electron microscope (TEM), or nanoparticle 
tracking analysis (NTA) and one molecular, based on protein markers (Western blot, flow cytometry), 
as suggested by the International Society for Extracellular Vesicles guidelines (ISEV) (on MISEV2014, 
[57]). However, regarding the criteria for the selection of exosomal markers found in published oEVs 
studies, there is not a common approach. Different exosomal markers have been used in oEVs studies 
such as: tetraspanins CD9 and CD81; heat shock proteins HSP70 (also known as HSPA1A) and HSC70 
(also known as HSPA8); as well as TSG101 and actin-linking ezrin-radixin-moesin (ERM) proteins 
(see Table 1). We believe that the lack of consensus reflects the current state of EVs research, since so 
far there is not a defined list of EV-specific “markers” that distinguish different subtypes of EVs, only 
different EVs-enriched proteins have been proposed by MISEV2014 and updated recently in more 
detail in MISEV2018 [55]. Moreover, the limited amount of oEVs as starting material makes it difficult 
to perform a deep characterization as recommended by MISEV2018 [55], leading researchers to limit 
the characterization experiments in favour of further omics analysis of the content and/or functional 
experiments in their studies. 
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Table 1. Summary of published studies related to oviductal extracellular vesicles (oEVs). 
Topic Species Year Findings 
Analyzed 
oEVS 
Content 
Characterization 
Method 
Exosomal 
Molecular Markers Citation 
Analysis of 
oEVs molecular 
content 
Bovine 2017 
 Identification of proteins from bovine 
oEVs cargo from in vivo and in vitro origin. 
 Oviductal EVs carry proteins associated 
to sperm-binding, fertilization and embryo 
development. 
Proteins TEM and WB HSP70 (WB) 
Almiñana et al., 2017 
Reproduction [24] 
Bovine 2018 
 Identification of mRNAs, small 
ncRNAs and proteins from bovine oEVs 
cargo across the estrous cycle. 
 Biological relevance of oEVs content on 
sperm/embryo and implications for the 
reproductive success. 
proteins, 
mRNA and 
small ncRNA 
TEM and WB 
HSP70 and ANXA1 
(WB) 
Almiñana et al., 2018 
BMC Genomics [37] 
Murine 2018 
 Identification of miRNAs from murine 
EVs cargo across the estrous cycle. 
 Biological relevance of miRNA derived 
from murine oEVs on sperm and embryo.  
miRNAs TEM and WB CD9 (WB) 
Fereshteh et al., 2018 
Scientific Reports 
[31] 
oEVs and their 
functional 
effects on 
gametes (sperm 
and oocyte) 
Murine 2013 
 Identification of EVs in the murine 
oviduct for first time and characterization. 
 Expression of Plasma Membrane Ca2+ 
ATPase 4a (PMCA4a) in the Murine female 
tract during estrous cycle and in oEVs: role 
in hyperactivated motility and fertility. 
 Transport of PMCA4a from oviduct to 
sperm: PMCA4a uptake by sperm via oEVs. 
protein 
PMCA4a 
TEM and WB 
HSC70 and CD9 
(WB); CD9 (TEM) 
Al-Dossary et al., 
2013 PLOS One [22] 
Murine 2015 
 Oviductosome-Sperm Membrane 
Interaction in Cargo Delivery: Detection of 
Fusion and Underlying Molecular Players 
Using Three-Dimensional Super-Resolution 
Structured Illumination Microscopy (SR-
SIM). 
No TEM and WB 
PMCA4 (TEM) 
CD9 (WB) 
Al-Dossary et al., 
2015 J Biol Chem [58] 
Avian 2017 
 Identification of oEVs from culture 
medium of Utero-vaginal junction and 
vagina cells from hens: Changes in 
No WB CD63 (WB) 
Huang et al., 2017 
Theriogenology [33] 
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localization and density of CD63-positive 
exosome-like substances in the hen oviduct. 
 Effect of oEVS on avian sperm viability 
and motility. 
Canine 2017 
 Identification of oviductal MVs from 
canine oviductal epithelial cells culture and 
characterization. 
 Oviductal MVs improve in vitro 
maturation of canine oocytes. 
 Oviductal MVs contain miRNAs (miR-
30b, miR-375 and miR-503) with roles in 
follicular growth and oocyte maturation. 
hsa-miR-30b, 
has-miR-375, 
cfa-miR-503 
NTA 
 
_ 
Lange-Consiglio et 
al., 2017 
Reproduction [34] 
Turtle 2017 
 Identification of oEVs from turtle 
oviducts and characterization. 
 Oviductal EVs contact with cilia and 
with the sperm membrane give this turtle a 
unique secretory morphology. 
No 
TEM and 
immunostaining 
CD63 
(Immunostaining) 
Waqas et al., 2017 J. 
Exp. Zool. [35] 
Murine 2018 
 Evidence of delivery of miRNA 
contained in oEVs to sperm. 
 Localization of miiR-34c-5p at the 
centrosome in the sperm after uptake. 
miRNAs TEM and WB 
CD9 (TEM) 
CD9 (WB) 
Fereshteh et al., 2018 
Sci Rep [31] 
Human/ 
Murine 
2018 
 Identification of EVs in the woman 
fallopian tubes for first time and 
characterization. 
 Oviductal EVs their fertility-
modulating proteins are conserved in 
humans. 
PMCA1 and PMCA4 in oEVS are 
enzymatically active and their activity 
increased in sperm after oEVs interaction. 
proteins 
(PMCA1-4) 
TEM anand WB 
PMCA4 (TEM) 
HSC70 (WB) 
Bathala et al., 2018 
Mol Hum Reprod 
[32] 
oEVs and their 
functional 
effects on the 
embryo(s) 
Bovine 2016 
 Oviductal EVs from in vitro origin 
(BOEC) improve embryo quality 
(number/cells and gene expression) and 
cryosurvival. 
No 
TEM, NTA and 
FC, WB 
CD9 and CD63 (FC) 
CD9, ERM and 
TSG101 (WB) 
Lopera-Vásquez et 
al., 2016 PLOS One 
[23] 
Bovine 2017 
 Embryos take oEVs up during in vitro 
culture.  
 Oviductal EVs improve embryo 
development and embryo quality. 
proteins TEM and WB HSP70 (WB) 
Almiñana et al., 2017 
Reproduction [24] 
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Bovine 2017 
 Identification and characterization 
oEVS from different regions of oviduct 
(ampulla and isthmus): differences in size 
and concentration of oEVS. 
 Oviductal EVs from ampulla and 
isthmus have different effect on in vitro 
embryo development: oEVs- isthmus 
derived induce a positive effect on embryo 
quality. 
No 
TEM, NTA and 
WB 
CD9, ERM and 
TSG101 (WB) 
Lopera-Vásquez et 
al., 2017 
Reproduction [59] 
Murine 2019 
 Differences in oEVs from murine donor 
and recipient oviductal fluid: donor higher 
concentrations and more protein than 
recipients. 
 Oviductal EVs from donors improve 
the efficiency of embryo transfer: improve 
birth rate via resisting apoptosis and 
promoting differentiation.  
No 
TEM; NTA; WB; 
BCA 
CD9 and HSP70 
(WB) 
Qu et al., 2019 
Reproduction, 
Fertility and 
Development [36] 
Other oEVs 
functions Murine 2017 
 Role of oEVs in the interaction between 
epithelial and mesenchymal cells: oEVs 
derived from mesenchymal cells modulate 
the oviductal ciliogenesis. 
mRNA (beta-
actin, 
GAPDH and 
Vimentin) 
TEM and WB 
CD9 and CD81(WB) 
C81 (TEM) 
Nakano et al., 2017 
Biochem & Biophys 
Res Com [60] 
TEM: transmission electron microscopy; NTA: nanoparticle tracking analysis; WB: Western blotting; FC: flow cytometry; BOEC: bovine oviductal epithelial cells; 
MVs: microvesicles; BCA: protein assay by bicinchoninic acid. All studies used ultracentrifugation as method to isolate oEVs, except for oEVs from turtle (Waqas et 
al., 2017), in which oEVs were not purified and were identified by immunohistochemistry and TEM. 
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The increasing research in EVs demands urgent standardized strategies for EVs isolation with 
high purity and high exosome yield as well as for EVs-specific “markers” to sufficiently characterize 
the different EV populations. Isolation strategies and specific markers will need to be re-adjusted for 
oEVs in a practicable manner. Until then, the conclusions about the molecular cargo and functions of 
oEVs should be discussed with caution, being aware that under different sampling conditions or 
different isolation strategies for oEVs, the results might be slightly different. This brings up the need 
for full reporting of oEVs experiments with detailed descriptions of sampling conditions, 
characterizations, omics analysis, and functional aspects for each experiment. 
In the present review, we attempt to bring together current knowledge of oEVs and their 
contribution to the maternal gamete/embryo dialogue. For a better understanding of the impact of 
the existing studies, we have categorized oEVs studies according to three different topics: 1) analysis 
of oEVs molecular content; 2) oEVs and their functional effects on gametes (sperm and oocyte); and 
3) oEVs and their functional effects on the embryo(s) (Table 1).  
2.1. Analysis of oEVs Molecular Content  
We have included in this section studies providing an extensive analysis of oEVs content at 
protein, mRNA or miRNA level. Studies analysing only a unique protein or a panel of a few proteins, 
mRNAs or miRNAs in oEVs are not included in this section; although they provide important 
information about the oEVs components, and thus they are discussed in Section 3 of this review 
(included in Table 1). Considering this, we found in the literature only three publications providing 
an extensive repertoire of oEVs molecular components so far. Two on bovine oEVs from our 
laboratory [24,37] and other one on murine oEVs by Fereshteh et al. [31]. In fact, only our study on 
bovine oEVs across the estrous cycle has performed a systematic study of the oEVs molecular content 
at different levels using the same samples [37]. In our first study on oEVs, we compared the protein 
content of oEVs released by OEC in vivo obtained by flushing the oviducts and in vitro obtained from 
primary culture of OEC [24]. Our study revealed considerable differences in the protein cargo 
between oEVs from in vivo and in vitro origin. This study led us to three important ideas: (1) that the 
oEVs may be under the hormonal regulation; (2) that caution needs to be taken when studies are only 
based on EVs derived from cell lines or primary culture and extrapolated to in vivo EVs biology and 
function; and (3) the need to further analyse the molecular components of oEVs, e.g., at the level of 
mRNAs and miRNAs. Recently, we performed the first extensive analysis of oEVs providing their 
molecular repertoire at protein, mRNA and small ncRNA level [37]. Our results showed the oEVs 
molecular content is under the hormonal influence of the estrous cycle. In the next section, we will 
discuss some of the different proteins, mRNAs and miRNAs that changed in their abundance in oEVs 
across the estrous cycle and their potential functions in the oviduct.  
2.2. Oviductal EVs and Their Functional Effect on Gametes 
Oviductal EVs were first described for their implications in sperm storage, promotion of 
capacitation and regulation of acrosome reaction and hyperactivated motility in mice [22]. Al-
Dossary and colleagues demonstrated that oEVs carry in their cargo plasma membrane Ca2+-ATPase 
4 protein (PMCA4), which is the major Ca2+ efflux pump in murine sperm [61]. Particularly, the 
PMCA4a form is predominant in the oviductal fluid compared to uterus and highly abundant during 
proestrus/estrus compared to other stages of the cycle. Moreover, PMCA4a is involved in the 
maintenance of Ca2+ homeostasis, prevent premature capacitation of the sperm and support sperm 
acquisition of fertilization potential [22]. Furthermore, it has been shown that deletion of the gene for 
PMCA4a leads to male sterility due to a loss of progressive and hyperactivated motility [62,63]. 
Spermatozoa acquire PMCA4a from the oviductal secretions via oEVs as demonstrated after in vitro 
co-incubation of oEVs with sperm [22].The mechanism by which oEVs deliver PMCA4a or other 
cargo to sperm cells is by integrin v3 and 5-mediated oEVs fusion to the sperm membrane [58]. 
Recently, oEVs were described in human oviductal secretions for the first time (Bathala et al., 
2018). Human oEVs carry also PMCA4 and eNOS which are fertility-modulating sperm proteins [62] 
and PMCA1, which leads to embryonic lethality in mice when deleted [63]. Bathala et al. [32] 
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suggested that all proteins identified to date in the cargo of murine oEVs with a fertility-modulatory 
role have a conserved function in human oEVs. 
On the other hand, Lange-Consiglio et al. [34] have shown that oEVs can exert also a functional 
effect on the female gamete, contributing to the oocyte maturation in the bitch. The canine oviductal 
environment has some unique features that contribute to the oocyte maturation in the oviduct. In the 
absence of this unique milieu in vitro, the canine oocyte maturation rates are very low. Lange-
Consiglio and colleagues [34] showed that the supplementation of in vitro maturation media with 
MVs from canine oviductal fluid improved significantly canine oocyte maturation rates. Moreover, 
these authors demonstrated that MVs can be taken up by the cumulus cells and later into the oocyte 
cytoplasm during in vitro maturation. Furthermore, these authors identified in oviductal cells and 
MVs three miRNAs (miR-30b, miR-375 and miR-503) with key roles in follicular growth and oocyte 
maturation. Considering that canine oocyte maturation occurs in the oviduct in contrast to other 
species, these miRNAs may be transferred from the oviductal cells to the oocytes via MVs to support 
oocyte maturation. In bovine, these three miRNAs were also found in follicular fluid EVs [64], where 
the oocyte maturation takes places, while only miR-30b and miR-375 were found in oEVs [37]. Lange-
Consiglio et al. [34] suggest that specific MVs cargo may be essential for canine oocyte maturation 
and thus the supplementation of MVs during canine IVM may have a great impact on the in vitro 
reproductive technologies for the canine species.  
2.3. Oviductal EVs and Their Functional Effect on Embryo(s) 
To date only four studies have shown functional effects of oEVs on embryos (Table 1). Almiñana 
et al. [24] showed that oEVs could be taken up by in vitro produced (IVP) embryos during in vitro 
culture (IVC). Moreover, this study showed that the oEVs supplementation during IVC improved 
embryo development in terms of blastocyst yields, hatching rates, in vitro survival and number of 
cells/embryo. Similar results were obtained by Qu et al. in mice [36] when they compared the effect 
of oEVs from the murine donor and recipient oviductal fluids on cleavage and blastocyst rate to 
observe a significant increase in blastocyst rates in oEVs by donors. Additionally, these authors 
demonstrated that oEVs from donors improved the efficiency of embryo transfer by increasing the 
birth rate. Besides, Lopera-Vázquez et al. [23] showed that oEVs supplementation exert an effect on 
embryo quality, by increasing also the number of cells and improving embryo cryosurvival after 
cryopreservation, although no effect was observed on the blastocyst yield. Furthermore, Lopera-
Vásquez and colleagues [59] showed differences in EVs concentration and size in different regions of 
the oviduct (ampulla and isthmus) and with different functional effects on the embryo. While Qu et 
al. [36] pointed out differences in oEVs from donors and recipients, with higher concentrations and 
more protein in oEVs from donors than recipients.  
Differences in the results obtained among studies could be due to two main reasons: 1) the 
hormonal influences on the oEVs content [37], since samples were collected from animals at different 
stages of the estrous cycle (early post-ovulatory stage, 1–4 days after ovulation [24] versus mid-luteal 
phase [23]), and 2) the different origin of oEVs (in vivo oEVs obtained after flushing of the oviducts 
versus oEVs obtained from conditioned media after primary culture of BOEC [23]), since it has been 
shown that oEVs from in vivo and in vitro origin have a different molecular cargo [24]. 
To prove that oEVs could have further effects on IVP embryos, Lopera-Vázquez et al. [59] 
analysed the embryonic gene expression of IVP embryos cultured with oEVs focusing on a panel of 
genes. Supplementation with oEVs altered gene expression in the embryo by the down-regulation of 
IFNT and PLAC8, genes related to implantation, when compared to the control. Interestingly, oEVs 
supplementation led to embryos with IFNT and PLAC8 expression patterns more similar to in vivo 
ones, since IFNT and PLAC8 have been found as down-regulated in in vivo embryos compared to in 
vitro counterparts [65,66]. On the other hand, Que et al. [36]showed that the supplementation of IVC 
media with murine oEVs alters the expression of genes related to apoptosis and cell proliferation 
(BAX, BCL2, OCT4) in the embryo. The use of oEVs from donors revealed a lower apoptotic index 
compared to recipients, suggesting improved embryo competency by repressing apoptosis and 
promoting differentiation. 
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Despite differences in the material of origin and isolation protocols, all studies mentioned above 
showed a positive effect of oEVs supplementation during in vitro culture on the embryo development 
by improving embryo development and quality [24]; embryo cryosurvival [23], embryonic gene 
expression [23] as well as birth rates [36]. Moreover, it has been shown that oEVs from isthmus 
compared to ampulla [59] and from oviducts from donors compared to receptors [36], improved IVP 
embryos in terms of blastocyst rates and birth rates. These results seem logical and may reflect the 
physiological needs of the embryo, since the early embryo is located in the isthmus, which sustains 
its development before migrating into the uterus. Furthermore, the exosome secretion/content seems 
to be different between donor and recipients despite hormonal treatments [36]. All these studies 
provide complementary findings regarding the functional effect of oEVs on the early embryo and 
their fate. Furthermore, they clearly showed that oEVs are an important part of the oviductal 
secretions with crucial effect on embryo development and therefore could be a good strategy to 
improve ARTs success. 
3. Oviductal EVs: Current Knowledge about Their Molecular Content 
3.1. Oviductal EVs and Proteins 
In bovine oEVs, 336 clusters of proteins were identified by mass spectrometry analysis [37]. 
Among them, we highlight the presence of proteins characteristic for the exosomal proteomics 
signature with different roles such as: exosome biogenesis (ESCRT-associated: VPS13C, FAM129B, 
PDCD6IP); intracellular vesicle trafficking and release (DYN-C1LI1; SNAP23, STXBP1); tetraspanins 
(CD9) and GTPases (RAB1A, RAB2A, RAB7A, RAB11A,RAB5C); exosome sorting (COPA, CLTC, 
ARF1, RAC1); annexin proteins involved in membrane trafficking and fusion events (ANXA1–8, 
ANXA10); and heat-shock proteins (HSPs) (HSP90, HSC70) involved in homeostasis and 
biosynthesis, transport and folding of proteins. Besides, we identified proteins characteristic for the 
oviduct with key roles during the gamete/embryo-oviduct cross talk such as: OVGP1, ANXA2, 
HSPA8, HSP90, HSP70, gelsolin and ezrin (discussed in [24]). Some of these proteins were among the 
25 most abundant proteins in oEVs, which could exert a functional effect on spermatozoa or embryos 
when they are taken up via oEVs. Proteins of the HSP family were identified (HSPB1, HSPA8, 
HSP90AA1 and HSPA1A), which are crucial for fertilization and early embryo development [67] and 
can exert anti-apoptotic effects and cryoprotection (HSPB1) [68]. Annexin family proteins have also 
been identified in oEVs in high abundance, and have been suggested to hold sperm in the oviductal 
reservoir (ANXA2) [69]. Interestingly, some proteins showed different patterns of abundance 
between post-ovulatory and pre-ovulatory stages of the estrous cycle, maybe adapting to their role 
on sperm and/or embryos. For example, MYH9 and CLTC were found to be more abundant at pre-
ovulatory stages, and potentially involved in the maintenance of sperm viability in the sperm 
reservoir [70]. While HSPA8, MIF and AQP5 were more abundant at post-ovulatory stages and may 
contribute to the release of spermatozoa from the sperm reservoir, sperm hyperactivation, and sperm 
transport to meet the oocyte, fertilization and early embryo development [71]. 
In murine oEVs, Al-Dossary and colleagues [22] identified a plasma membrane Ca+2-ATPase 4 
(PMCA4), which is involved in controlling progressive and hyperactivated sperm motility. While 
Griffiths et al. [72] identified sperm adhesion molecule 1 (SPAM1), contributing to enhance 
hyaluronic acid-binding ability and cumulus penetration efficiency. Bathala et al. [32] identified the 
presence of tyrosine phosphorylated sperm proteins that play a critical role in sperm capacitation 
and that can be delivered to sperm via oEVs. Additionally, these authors identified two proteins, 
calcium/calmodulin-dependent serine kinase (CASK) and neuronal nitric oxide synthase (nNOS), 
which interact with PMCA4, as well as PMCA1 which is present in murine oEVs in a functional 
complex. However, most of the proteins identified in murine oEVs were not identified in bovine 
oEVs, which could be explained by differences in oEVS isolation protocols, the proteomic approach 
or species-specific differences [24,37]. 
Table 2 summarizes proteins identified in oEVs in mouse and human and the 25 most abundant 
in bovine. As Table 2 shows, only two proteins overlap among species, heat shock protein family A 
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(Hsp70) member 8 (HSPA8) and actin beta (ACTB). This could be mainly due to the different 
approaches and methodologies used in bovine, murine and human studies (focusing on specific 
proteins by Western Blotting versus extensive analysis of oEVs proteins by mass spectrometry). It is 
worth mentioning that HSPA8, is a protein commonly used as exosomal marker but also a protein 
with a key role in the oviduct. It has been identified in a subset of 70 kDa oviductal surface proteins 
that bound to spermatozoa. Different roles have been attributed to this protein: mediating oviduct-
gamete interactions, enhancing survival of spermatozoa, and improving sperm fertilizing ability 
[73,74]. 
3.2. Oviductal EVs and mRNA 
Our recent study analysing the oEVs mRNA content across the estrous cycle identified a high 
number of transcripts corresponding to 13,197 genes [37]. However, most of the transcripts occurred 
at low a copy numbers and only the top 500 most abundant transcripts showed a frequency of more 
than 25 transcripts per million. We set this arbitrary threshold to point out oEVs transcripts that may 
exert a functional effect on spermatozoa and embryos, since we hypothesize that mRNA content at 
low concentration is less likely to induce an effect and to distinguish from possible contaminations 
on EVs pellet as a result of the purification method. Among the identified mRNAs, mRNAs encoding 
ribosomal proteins and translation elongation factors were the most abundant protein-coding RNAs 
in oEVs. Ribosomal proteins play a crucial role in protein translation, immune signalling and 
development [75]. It is possible that mRNAs encoding ribosomal proteins, translation factors as well 
as tRNAs and rRNAs, contained in oEVs, may participate in protein translation upon arrival to 
embryos. 
Functional analysis of oEVs content showed that oEVs were enriched in mRNA associated to 
embryo development, cell proliferation and epigenetic regulation. We identified an important 
number of genes involved in chromatin modification including histone methyltransferases (EHMT1, 
EHMT2, EZH1, KMT2A, KMT2B, KMT2C, PHF1, PHF2, PRMT5, SETD1A, SETD2) and histone 
demethylases (ARID5B, JMJD1C, KDM2A, KDM3B, KDM5B, KDM5C, KDM6B), but also one DNA 
methyltransferase gene (DNMT1). This finding suggests that chromatin modification in the early 
embryo could be in part under maternal control via oEVs transcripts. Moreover, considering that 
altered DNA methylation patterns are induced in the embryo by suboptimal culture conditions [76], 
we hypothesize that oEVs supplementation during in vitro culture could revert in parts those 
epigenetic modifications in the pre-implantation embryo. 
Pointing out at specific mRNA components of oEVs with potential roles on gametes/ embryos, 
tumour protein translationally-controlled 1 (TPT1) was the most frequent mRNA identified in oEVs, 
which has been associated with the activation of pluripotency genes such as NANOG and OCT4 in 
oocytes [77]. The protein encoded by another mRNA highly abundant in oEVs, receptor of activated 
protein kinase C 1 (RACK1) has been found in higher abundance in bovine blastocysts compared to 
morula [78]. We also identified in oEVs genes involved in transcription and translation (CNOT1, 
EEF1G, PABPN1, FOXO3A, DOT1L) and in metabolism (GALE, HEBP1) which has been found 
suppressed in in vitro embryos compared to in vivo ones [79]. Different mRNAs for CATSPER units, 
which are involved in sperm Ca2+ channels and associated to sperm fertility were also identified in 
oEVs. 
Nakano et a., [60], showed that vimentin, GAPDH and ACTB mRNAs are also components of 
murine oEVs isolated from oviductal mesenchymal cell line (S1), which were also identified in bovine 
oEVs in our study. Moreover, they demonstrated that these specific mRNAs from an oviductal 
mesenchymal cell line were able to be transported into cells of Müllerian epithelial cell line (E1) via 
oEVs and exert a functional effect by increasing the number of ciliated cells. On the other hand, 
Lopera-Vásquez et al. [23] showed an upregulated expression of connexin 43 (GJA1) and also GAPDH 
in in vitro produced embryos after oEVs supplementation during culture. Although these authors 
did not analyze the EVs content, our study [37] identified GJA1 and GAPDH mRNAs in oEVs, which 
are associated with better quality embryos and cryotolerance [80].
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Table 2. Proteins identified in oviductal extracellular vesicles (oEVs) in different species. 
Bovine Murine Human 
Protein Description Symbol Protein Description Symbol Protein Description Symbol 
oviductal glycoprotein 1 OVGP1 Plasma membrane calcium-transporting ATPase 4 PMCA4 
Plasma membrane calcium-
transporting ATPase 4 PMCA4 
annexin A1 ANXA1 
Plasma membrane calcium-
transporting ATPase 1 PMCA1 
Plasma membrane calcium-
transporting ATPase 1 PMCA1 
tubulin, beta 2B class IIb TUBB2B Endothelial nitric oxide synthase eNOS 
(NOS3) 
Endothelial nitric oxide 
synthase 
eNOS 
(NOS3) 
annexin A2 ANXA2 neuronal nitric oxide synthase  nNOS 
(NOS1) 
neuronal nitric oxide synthase  nNOS 
(NOS1) 
annexin A4 ANXA4 
calcium/calmodulin- dependent 
serine kinase  CASK 
calcium/calmodulin-
dependent serine kinase CASK 
heat shock protein family A (Hsp70) 
member 8 HSPA8 
heat shock protein family A 
(Hsp70) member 8 
HSPA8 
(HSC70) 
heat shock protein family A 
(Hsp70) member 8 
HSPA8 
(HSC70) 
actin beta ACTB actin beta ACTB actin beta ACTB 
CD109 molecule CD109     
tubulin, alpha 3e TUBA3E     
annexin A5 ANXA5     
heat shock 70kDa protein 1A 
HSPA1
A     
heat shock protein 90 alpha family 
class A member 1 
HSP90A
A1 
    
5'-nucleotidase ecto NT5E     
annexin A8-like 1 
ANXA8
L1     
ezrin EZR     
clathrin heavy chain CLTC     
glyceraldehyde-3-phosphate 
dehydrogenase 
GAPDH     
stomatin STOM     
mesothelin MSLN     
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major vault protein MVP     
annexin A11 ANXA1
1 
    
ectonucleotide 
pyrophosphatase/phosphodiesterase 3 ENPP3     
heat shock protein family B (small) 
member 1 HSPB1     
clusterin CLU     
RAB5C, member RAS oncogene family RAB5C     
Bovine: Only the 25 most abundant proteins are shown in the table. A complete list of the bovine oEVS proteins identified by Mass Spectrometry so far can be found 
in Almiñana et al., 2018. Murine: Murine oEVs proteins have been identified by Western blot immunolabeling (source: Bathala et al., 2018). Human: Human oEVs 
proteins have been identified by Western blot or immunolabeling (source: Bathala et al., 2018). 
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3.3. Oviductal EVs and miRNA 
So far, only two publications have performed an extensive analysis of miRNA in oEVs across 
the estrous cycle, identifying 272 miRNAs and 184 miRNAs in murine and bovine oEVs, respectively 
[31,37]. Both studies showed a hormonal effect of the estrous cycle; however, the number of 
differentially miRNAs among stages was not very high in either study. Fereshteh et al. [31] suggested 
that miRNAs expression levels did not appear to vary much throughout the estrous cycle, which may 
be due to the mixture of oEVs from stage 1–2 and stage 3–4 in their study. However, Almiñana et al. 
[37] analysed the four stages separately and did not find a high number of differential miRNAs 
among stages (13 out of 184 identified). Nevertheless, great differences where observed at mRNA, 
proteins and other non-coding RNA such as small nuclear RNAs in the same samples of oEVs [37]. 
Comparing miRNAs identified in oEVs from murine (272) [31] and bovine (184) [37]studies, we 
found that 91 miRNAs were in common, while 93 were unique to bovine and 183 to murine oEVs. 
These results may point out common and species-specific molecular components of oEVs, which may 
participate in the gamete/embryo-oviduct cross-talk in a species-specific manner. Since monotocous 
and polytocous species have shown differences in gamete/embryo maternal interactions [81]. 
However, it is worth mentioning that some differences in miRNAs content could also be due to the 
use of different oEVs isolation protocols and differences in RNA-sequencing analysis (mainly small 
RNA library preparation [82]). Moreover, it is important to consider annotation issues, since more 
miRNAs are known for mice than for cattle. Additionally, differences in miRNAs annotation 
according to the species make it difficult to perform direct comparisons among species and can 
mislead the numbers of common or specific miRNAs in each species. 
In canine oEVs, three miRNAs have been identified by Consiglio et al. [34] (miR-30b, miR-375 
and miR-503), particularly in MVs from canine oviductal fluid with key roles in follicular growth and 
oocyte maturation. Two of them (miR-30b and miR-375) were also present in bovine and murine oEVs 
miRNA [31,37]. Interestingly, miR-375 associated to amino sugar and nucleotide sugar metabolism 
[37] and involved in cell fate determination in the early embryo [83], and it was significantly different 
among stages of the estrous cycle (stage 3 compared to stage 1) in the study of Almiñana et al. [37]. 
In an attempt to provide a comprehensive analysis of oEVs-derived miRNAs and their potential 
target genes in embryos, we used the miRNet online tool, an integrated platform linking miRNA 
targets and functions (https://www.mirnet.ca/) [84], with lists of miRNAs differential and highly 
abundant in bovine oEVs [37]. This analysis revealed that a considerable number of miRNAs 
contained in oEVs target genes involved in embryo development, embryo morphology or 
implantation as represented in the networks of Figure 1 and Figure 2. Since the miRNet online tool 
allows to choose the source/tissue for the list of miRNAs, we selected miRNAs contained in exosomes 
for the network in Figure 1 and in embryos for Figure 2. Figure 1 shows that 11 out of 13 miRNAs 
were present in EVs in the online tool database (Figure 1a), with all of them targeting genes involved 
in embryo development (Figure 1b). Figure 2 shows that only 3 miRNAs found in oEVs were also 
found in embryos according to the miRNet database (Figure 2a) and target also genes involved in 
embryo development (Figure 2a). In a similar way, Fereshteh et al. [31] showed that oEVs miRNA 
target genes involved in embryo development including BCL2, CDK6 and c-MYC [85,86].  
Regarding functional studies of oEVs-derived miRNAs with gametes, Fereshteh et al. [31] 
showed recently that murine oEVs can deliver miRNAs to sperm, particularly: miR-143-3p, miR-22-
3p, and miR-34c-5p, which are associated to reproductive processes such as embryo implantation, 
spermatogenesis and the early zygote [85,87]. Individual miRNAs were predominantly localized in 
specific head compartments, with miR-34c-5p being highly concentrated at the centrosome. 
Interestingly, miR-34c-5p, is essential for the first cleavage and is solely sperm-derived in the zygote. 
MiR-34c-5p was also identified in bovine oEVs [37] and could have been taken up by embryos after 
oEVs incubation during IVC [24], but so far this has not been shown. For miR-30d contained in oEVs 
and also in uterine EVs, there is evidence for uptake by mouse embryos [88]. The results of Fereshteh 
et al. [31] show that oEVs are capable of contributing to the sperm’s miRNA repertoire and exert an 
effect with physiological relevance to the sperm. 
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Figure 1. Networks of selected miRNAs identified in oviductal extracellular vesicles (oEVs) and 
potential target genes involved in embryo development. The miRNet online tool was used to 
represent selected miRNAs (13) (turquoise-blue nodes) based on differential expression and high 
abundance in oEVs at stage 1 of the bovine estrous cycle (recently ovulated follicle; days 1–4 post-
ovulation) and potential target genes (red nodes) enriched in functional categories related to embryo 
development (green), embryo morphology (blue) and implantation (yellow) in a network. Since the 
miRNet online tool allows to choose the source/tissue for the list of miRNAs, network (a) represents 
11 miRNAs contained in exosomes in the online tool database, with all target genes involved in 
embryo development. Network (b) represents 3 miRNAs contained in embryos in the online tool 
database, with all target genes involved in embryo development functions. 
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Figure 2. Networks of selected miRNAs identified in oviductal extracellular vesicles (oEVs) and 
contained in the embryo according to miRNet online tool with potential target genes involved in 
embryo development. The miRNet online tool was used to represent selected miRNAs (13) 
(turquoise-blue nodes) based on differential expression and high abundance in oEVs at stage 1 of the 
bovine estrous cycle (recently ovulated follicle; days 1-4 post-ovulation) and potential target genes 
(red nodes) enriched in functional categories related to embryo development (green), embryo 
morphology (blue) and implantation (yellow) in a network. Since the miRNet online tool allows to 
choose the source/tissue for the list of miRNAs, the network (a) represents three miRNAs contained 
in embryos according to the online tool database, with all target genes involved in embryo 
development functions (b). 
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3.4. Oviductal EVs and other Molecular Cargo 
Lipids, other small molecules and metabolites are also essential components of EVs [89,90]. To 
the best of our knowledge, no lipidomic or metabolomic analyses of oEVs have been performed so 
far. Having a look into the literature, it is not surprising since not many metabolomics studies have 
been published in the field of female reproduction. The metabolomic profiling of the bovine oviductal 
fluid across the estrous cycle has been performed recently [91]. While lipidomic studies on the oviduct 
have focused only on analysing specific lipids in a short time window after ovulation (day 4) [92]. 
Furthermore, metabolomic investigations were focused on the embryo culture medium with the idea 
to find biomarkers for embryo selection or on the follicular fluid to predict oocyte quality [93,94].  
Although, small molecules of oEVs have not been studied yet, results of exosome from other 
sources suggest potential functions of these molecules also in the maternal-gamete/embryo 
communication. For example, recent studies have shown that exosomes derived from immune cells 
and other cells contain bioactive lipids, such as prostaglandins, leukotrienes, and lysophospholipids 
and may transfer them to specific target cells (reviewed in [95]). Given the importance of 
prostaglandins in reproductive processes [96], targeted transport of prostaglandins to the early 
embryo or from the embryo to oviduct epithelial cells could be possible. 
Overall, the characterization of the oEVs metabolomic and lipidomic profile could allow the 
identification and quantitation of an extensive variety of molecules indicative of metabolic, 
nutritional as well as the physiological and pathological status of the cells of origin, animal or patient. 
These valuable data will complement our current knowledge about the oEVs at transcriptomic and 
proteomic level, increasing our understanding of the potential role of oEVs during the early 
reproductive events. Moreover, the exosomal lipid composition is essential for the formation and 
release of exosomes [97], which is an important point to consider when we aim to use EVs/exosomes 
as drug delivery vehicles.  
3.5. Regulation of the Dynamic and Complex Oviductal EVs Molecular Cargo 
Aside from the extensive identification of oEVs molecular components, our laboratory provided 
with clear evidence that the oEVs content is under hormonal regulation with marked differences 
between the pre-ovulatory stage and post-ovulatory stages of the estrous cycle at mRNA, protein and 
small noncoding RNA level [37]. This agrees with the results of transcriptome and proteome studies 
of the oviduct during the estrous cycle [16,98–101]. Furthermore, Greening and colleagues [102] 
showed that the EVs protein cargo derived from a human endometrial cell line was also under 
hormonal regulation. Furthermore, Burns et al. [103] recently showed that exogenous progesterone 
treatment (P4) regulates uterine EVs production and their mRNA and miRNA cargo in the uterine 
lumen of sheep. Additionally, these authors demonstrated that the molecular content varies between 
pregnant and cyclic animals by showing differential protein abundance in uterine EVs collected from 
day 14 pregnant sheep versus cyclic controls [104]. These findings suggest differential loading of EVs 
components derived from the endometrial epithelia or from the conceptus. Moreover, these results 
support the idea that uterine EVs play a key role in conceptus-endometrial interactions, crucial for 
the establishment and maintenance of pregnancy. 
A more detailed analysis of the hormonal influence of the estrous cycle on selected components 
of oEVs cargo, provided a very dynamic and complex profile of proteins, mRNAs and miRNAs 
(Figure 3). The miRNAs, mRNAs and proteins represented in Figure 3 showed the most pronounced 
and representative changes with respect to typical expression profiles during the estrous cycle in 
oEVs in our study, mainly with marked differences between post- and pre-ovulatory stage (stage 1 
and stage 4). At the miRNA level, two different abundance patterns for 4 selected miRNAs were 
found (Figure 3a). While bta-miR-24-3p and bta-miR-10b-5p were downregulated in stage 1 and 
upregulated in stage 4, bta-miR-429 and bta-miR-449a concentration was highest in stage 1 and 
lowest for stage 3. At mRNA level, biggest differences in mRNA abundance were found in stage 1 
compared to the other stages, being some mRNAs upregulated while others downregulated in stage 
1 (Figure 3b). In contrast, the mRNA abundance was more or less stable across the rest of the stages 
analysed (stage 2–4). Some proteins showed a biphasic pattern of abundance with highest 
Bioengineering 2019, 6, 32 17 of 26 
concentrations in stages 1 and 3 (see Figure 3c). These findings show a differential loading of oEVs 
content in the oviduct across the estrous cycle and highlight the biggest differences at the 
postovulatory stage (stage 1, 0–4 days after ovulation), the time for arrival of gametes, fertilization 
and early embryo development. 
 
Figure 3. Profiles of miRNAs, mRNAs, and proteins during the estrous cycle in bovine oviductal 
extracellular vesicles (oEVs). MicroRNAs (a), mRNAs (b), and proteins (c) showing the most 
pronounced and representative changes with respect to typical expression profiles during the estrous 
cycle in oEVs were selected. Similar profiles are shown in related colors. Relative expression is shown 
as mean-centered expression values (log2-transformed expression value of the stage minus mean of 
all 4 stages). Stage 1: recently ovulated follicle (days 1–4 post-ovulation (po)); stage 2: early luteal 
development with medium or large follicles or both present (days 5–11 po); stage 3: fully functional 
corpus luteum (CL) yellow or orange in color (days 11–17 po); stage 4: regressing CL with little 
vasculature and a large preovulatory follicle present (days 18–20 po). 
Having these results in mind, and with the idea of performing further studies on the oEVs cargo 
under different reproductive scenarios, we would like to mention some of our concerns that may be 
also applied to other reproductive studies: (1) Samples from our study were collected from abattoir 
animals and classified according to the ovary status [37], a more accurate classification using 
synchronized animals and collecting samples for a specific day of the cycle could reveal slightly 
different results; (2) The results for one specific stage are the mean of abundance of all samples 
collected between different days (for example for stage 1, from day 1-4 post-ovulation), it is possible 
that there are also differences among days in this short window of time; (3) Samples from animals 
under different nutritional, housing (e.g., temperature, stress), animal management conditions or 
other factors such as animal age or breed can also affect the EVs population and cargo; (4) To obtain 
a considerable amount of EVs for omics studies, oEVs from our study represent a mixture of the two 
oviducts of the same animal. It is possible that there are differences in the oEVs population and 
content between ipsi-and contralateral oviducts and also between regions of the oviduct ampulla and 
isthmus, as Lopera-Vásquez results suggested [59]. These authors pointed out that the isthmus had 
a higher concentration of smaller vesicles compared to the ampulla. 
Considering the great hormonal effect on the oEVs cargo observed in our study, we raise the 
question whether the arrival of spermatozoa and/or embryos into the oviduct could also modulate 
the oEVs molecular components. Previous studies have shown that the OEC and oviductal fluid alter 
their composition in response to sperm and/or embryos [4,6,7]. As oEVs are major components of OF, we 
hypothesize that the oEVs may follow a similar pattern as a part of the oviductal response to 
gametes/embryos to support the success of the early reproductive events. Furthermore, it raises the 
question if oEVs may also differ under conditions of infertility or repeated pregnancy failure, in the 
present of unhealthy gametes/embryos. Further investigations determining the secretion/release of oEVs 
under different reproductive scenarios or conditions will bring some light to this important matter. 
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4. Oviductal EVs and Their Potential as Therapeutic Vectors 
The increasing number of reviews published in the last five years on the role of EVs in 
reproduction, underlines their importance in the early reproductive events, and also highlights their 
potential as therapeutic vectors and diagnostic tools in ARTs [26,28–30,105–109]. However, only a 
very few studies have provided molecular proofs of the role of EVs in the oviduct that promote their 
use to improve ARTs outcomes. In this review, we drew together findings from oEVs studies focusing 
on the oEVs components at protein, mRNA or miRNA level that may modulate the dialogue between 
the gametes/embryo and the oviductal environment. The transfer of proteins from the oviduct to 
sperm/embryos via oEVs may help sperm, in the decapacitation/capacitation events and promoting 
fertilizing ability [22,32], while for embryos, oEVs may support the early embryo development 
processes [24]. The transfer of mRNAs could lead to the generation of functional proteins by the 
embryo while transferring genetic information. The transfer of miRNAs could have a remarkable 
impact on the regulation of gene expression. Altogether, these findings suggest oEVs represent ideal 
natural nanoshuttles for carrying a “cocktail” of proteins, transcripts and miRNAs that are not 
present in the in vitro culture of gametes and embryos, or are altered after gametes/embryos are 
subjected to sperm handling and ARTs procedures. 
In this regard, on the sperm side, studies have shown differences in transcript abundance in 
sperm after cryopreservation [110], and particularly, differences in miRNAs in fertile versus 
subfertile [111] and low versus high motile, cryopreserved sperm in bulls [112]. The transfer of 
specific transcripts into sperm have important implications in fertility, since some sperm RNAs are 
delivered into the zygotes and regulate cell signaling processes or regulate epigenetic events during 
early embryo development [110]. On the embryo side, comparative studies regarding the quality of 
embryos derived from ART versus in vivo embryos have shown important differences in the 
embryonic transcriptome and proteome profiles. For example, the suppressed expression of genes 
involved in transcription and translation (CNOT1, EEF1G, PABPN1, FOXO3A, DOT1L) and 
metabolism (GALE, HEBP1) [79] and reduced expression of annexins 1 and 2 proteins in IVP embryos, 
with important functions in the maintenance of placentation [113]. Considering these findings, the 
use of oEVs seems a good strategy to overcome in vitro culture deficiencies and promote successful 
pregnancy when ARTs are applied.  
For the practical application of oEVs, different sources of oviductal secretions can be considered 
as a starting material, for example: in vivo oviducts, when it is possible, or in vitro conditioned media 
obtained from primary culture of OEC or immortalized OEC cell lines. Caution should be taken when 
in vitro material is used, since differences in protein composition have been shown between in vivo 
and in vitro oEVs [37]. Being aware of these differences, oEVs could be loaded by co-incubation or 
electroporation with specific components (proteins, miRNA) that are not present in in vitro, or with 
components that could exert a specific effect in gametes/and embryos. 
Then, oEVs could be applied to: a) sperm: to bring decapacitation factors during sperm-pre-
incubation or washing steps in ARTs procedures or after cryopreservation, since it is known that 
sperm handling procedures and storage induce sperm surface changes and damage with important 
consequences for sperm survival and fertilization competence [114]; b) oocytes: to improve in vitro 
maturation rates, as shown by Lange-Consiglio et al. [34] or to improve blastocyst yield, since the 
intrinsic quality of the oocyte is the main factor affecting blastocyst yield [115]; c) embryos, during 
IVC to improve embryo development and quality, as recent studies have shown [23,24,36], since the 
post-fertilization culture conditions constitute the main factor affecting the quality of the blastocyst 
[116]; and also by supplementing ET media, to improve pregnancy and birth rates [36]. 
5. Challenges and Future Directions for oEVs Research 
Research in the field of reproductive EVs has increased exponentially in the last decade. More 
recent investigations are focusing on the role of oEVs in the early reproductive events. These studies 
clearly show that oEVs play a crucial role in sperm capacitation and fertilizing ability, oocyte 
maturation, fertilization and early embryo development, which are the first crucial events for 
pregnancy success. It furthermore calls for a better understanding of the molecular mechanisms 
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mediating the gamete/embryo-oviductal cross talk, before oEVs research can be translated to 
therapeutic approaches to improve the outcomes of natural pregnancy and increase pregnancy rates 
in ARTs in livestock and humans. 
As discussed throughout this review, future efforts should be directed to: (1) standardization of 
isolation and purification methods for EVs that can be adapted for oEVs, of which the availability 
and quantity is very limited compared to other reproductive EVs; (2) well-defined markers for the 
characterization of heterogeneous EVs subpopulations in the oviduct (exosomes and MVs); which 
will allow comparisons among studies; (3) deep analyses of oEVs molecular cargo under 
physiological and pathological conditions using advanced proteomic and sequencing technologies, 
which is crucial to identify the targets in the potential recipient cells (gametes/embryo); (4) this should 
come along with functional studies, which will help to understand the molecular signalling networks 
triggered by oEVs in gametes/and embryos; (5) studies on specific mechanism of oEVs uptake by 
sperm, oocyte and embryo (recognition of oEVs and entering into the cell); (6) studies on cargo 
delivery, i.e., what is released into the cell and what is the destiny of the delivered molecules; and (7) 
finally, but no less important, defining the extent of the oEVs effects in the reproductive events, from 
gametes and embryos to the delivery of healthy descendants and their impact on adulthood.  
Considering the work ahead, the therapeutic application of oEVs outlined above seems far away. 
However, recent guidelines published by ISEV about developing best practice models for EVs 
therapeutic use and their application in clinical trials [117,118], together with the number of early-
phase clinical trials with EVs that have been already undertaken (reviewed by [119]), shows that 
progress is being made towards promoting safe approaches for clinical therapeutic applications of 
EVs [120]. Future research facing current challenges in reproductive EVs and particularly in oEVs, 
will ensure advances in the potential application of oEVs to maximize pregnancy rates in natural and 
in in vitro fertilization treatments. 
6. Concluding Remarks 
In this review, we attempted to bring together current knowledge of EVs in the oviductal 
environment, from isolation, characterization, description of the EVs molecular content and 
associated functional aspects in different species. The potential role of oEVs as modulators of 
gamete/embryo-oviduct interactions and their implications in the success of the early reproductive 
events has been addressed. Our review points out current challenges in oEVs research, emphasizing 
the need for further descriptive and functional research on oEVs under different physiological and 
pathological conditions. This will allow to set directions for the potential application of oEVs as 
therapeutic vectors to improve the diagnosis and treatment of pregnancy disorders, infertility 
problems and increase the success of ARTs. 
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